Martin Mansergh, an adviser on Northern Ireland to three Fianna Fáil taoisigh who went on to serve as a senator, TD and minister of State, has died. Mr Mansergh is understood to have died while in ...

The funeral of Martin Mansergh, politician and adviser on Northern Ireland to three Fianna Fáil taoisigh, is to be held in Co Tipperary. Mr Mansergh died in Morocco last week. His remains will be ...

Tributes have been paid to former junior minister and key Northern Ireland peace process adviser Martin Mansergh, who has died aged 78. Taoiseach and Fianna Fáil leader Micheál Martin said he learned ...

Mina has been playing video games for her whole life. She hails from Virginia in the USA, and she loves cozy games, FPSs, MMOs, and puzzle games. She lives in Richmond with her husband and her kitty, ...

There are plenty of rivalries in the US launch industry. People who build big and brawny machines tend to have egos to match. And if you chat up the senior executives of these rocket companies offline ...

President Trump was subject to some technical difficulties on Tuesday morning while giving a speech at the UN, saying his teleprompter wasn’t working. He then immediately threatened the operator of ...

Advanced Micro Devices Inc.’s biggest rival in graphics processing units is teaming up with its biggest rival in central processing units. Does that spell trouble for the chip company? Britney Nguyen ...

In previous years, Windows laptops often struggled with issues like short battery life, slow processing speeds, and overheating. A 2024 PCMag survey found that nearly 40% of users identified battery ...

Agentic AI is almost certain to upend banks' traditional business models. Early adopters may be able to grab an advantage, while laggards will be fighting over diminished profits, warn Pradip Patiath ...

The autumnal or fall equinox arrives on Monday, September 22, 2025, at 2:19 P.M. EDT, bringing with it the sound of dead leaves, the rich rot of pumpkin spice and the distant echo of frost. An equinox ...

A phase 2b trial of Enanta Pharmaceuticals’ respiratory syncytial virus (RSV) drug candidate has missed its primary endpoint. But, with other analyses generating signs of efficacy, the biotech made ...